...
首页> 外文期刊>Cancer causes and control: CCC >Use of biomarkers in epidemiologic studies: minimizing the influence of measurement error in the study design and analysis.
【24h】

Use of biomarkers in epidemiologic studies: minimizing the influence of measurement error in the study design and analysis.

机译:在流行病学研究中使用生物标志物:最大程度地减少测量误差在研究设计和分析中的影响。

获取原文
获取原文并翻译 | 示例
           

摘要

The inclusion of biomarkers measured on the continuous scale, such as endogenous sex hormones or antioxidant levels, has become common in epidemiologic studies, and introduces additional sources of error that are specific to biomarkers. This includes error associated with specimen collection, processing, and storage; laboratory error (both within and between batch); and variability in the biomarker levels over time within an individual. In this review, we discuss and recommend study design and analytic strategies to deal with these sources of measurement error. In particular we describe methods to prevent or minimize some sources of error through appropriate sample collection and storage, communication with the laboratory, proper batching of samples, and participant matching. We also discuss how to quantify error related to biomarkers, focusing on issues of quality control, pilot studies, and how to measure within-person stability over time. Further, we discuss analytic issues for dealing with laboratory and within-person variability. Finally we recommend that journals standardize the reporting of biomarker assays in scientific manuscripts.
机译:在流行病学研究中,以连续尺度测量的生物标志物(例如内源性激素或抗氧化剂水平)的纳入已变得很普遍,并引入了特定于生物标志物的其他误差来源。这包括与标本采集,处理和存储有关的错误;实验室误差(批次内和批次之间);个体内生物标志物水平的变化。在这篇综述中,我们讨论并推荐研究设计和分析策略来应对这些测量误差源。特别是,我们描述了通过适当的样品收集和存储,与实验室的交流,适当的样品分批和参与者匹配来防止或最大程度减少某些错误源的方法。我们还将讨论如何量化与生物标志物有关的错误,重点是质量控制,试点研究以及如何衡量人员随时间的稳定性。此外,我们讨论了处理实验室和人际变异性的分析问题。最后,我们建议期刊对科学手稿中生物标志物测定的报告进行标准化。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号